The Most Exciting Metabolic Drug You've Never Heard Of (ATX-304)
This new compound doesn’t just lower blood sugar. It mimics many of the metabolic effects of exercise. The data behind ATX-304 are hard to ignore, as are the real-world reports.
I don’t say this lightly: this may be one of the most interesting metabolic drugs I’ve ever reviewed.
Officially, it’s in clinical trials for diabetes.
Unofficially, it may represent something much bigger—a compound that reproduces some of the core metabolic effects of exercise itself.
If the early data continue to hold up, this could reshape how we think about treating insulin resistance, fatty liver, obesity, GLP-1s, and even exercise mimetics.
But before we get to the preclinical data and the human trials, I need to build a bit of biological foundation first.
AMPK: The Cell’s Fuel Gauge
The theory, and the challenges, begin with one of the body’s master metabolic regulators: AMPK.
AMPK functions as a kind of cellular fuel gauge.
During exercise, cells rapidly consume ATP—the body’s immediate energy currency.
As ATP levels fall, AMP levels rise, signaling that the cell is running low on available energy. In response, AMPK switches “on” and shifts the body away from energy storage and toward energy production.
If you want a cute mental image, it’s almost like AMPK flips “on” and the cell starts playing: “Burn, baby, burn—fat and carbs inferno!”
What? Too much? Sorry. Good song.
Anyway, the point is, AMPK activation leads to:
Increased muscle glucose uptake
Accelerated fat burning
Increased energy expenditure
In theory, safely activating this pathway could mimic many of the metabolic effects of exercise.
It could lower blood sugar and improve insulin sensitivity—hence the “diabetes drug” framing.
However, it could also:
Reduce fatty liver
Increase calorie burn (more on that in a moment)
Promote fat loss without muscle loss
So, for a long time, AMPK has been a highly desirable metabolic target.
But there’s been a challenge: manipulating AMPK safely has historically been difficult.
Activate it improperly, and you can end up pulling fuel into tissues without adequately burning it off—creating metabolic “traffic jams,” including excessive glycogen buildup in the heart. Not ideal. Highly efficient biceps are not much use if your heart has turned into that of a Sour Patch Kid.
But this new molecule, ATX-304, is different!
What is ATX-304?
At a high level, ATX-304 is an orally available “AMPK activator.”
Technically, it works by inhibiting the protein that naturally turns AMPK “off.” So it’s actually an inhibitor of an inhibitor. But to avoid confusing double negatives, we’ll simply refer to ATX-304 as an AMPK activator.
Of note, it’s not a peptide. It’s not injectable.
It’s a small molecule you can swallow in pill form with multifaceted effects on metabolism—including AMPK activation and apparent increases in energy expenditure.
In other words, it delivers a kind of metabolic one-two punch: pull fuel into cells, then burn it.
And that’s exactly what you’d want from an exercise mimetic.
So far, the data appear remarkably consistent with that hypothesis.
In animals and early human trials: researchers are seeing improvements in glucose handling, insulin sensitivity, fatty liver, and body composition.
In phase II human trials: patients with diabetes demonstrated improved blood sugar control, improved microvascular circulation, and reduced blood pressure.
But enough telling.
Let me show you the data.
And then we’ll talk about how people are already using ATX-304.
The Mouse Data
Let’s start with proof of concept in animals. Then we’ll move to humans.
Take a look at the graph below.
In this experiment, researchers started two groups of mice on an obesogenic high-sugar, high-fat diet.
However, one group also received ATX-304 (also called O304—because apparently they just wanted to confuse all of us).
The group initially receiving ATX-304 is represented by black triangles.
And you can see that, for the first 15 days, they gained essentially no weight despite the obesogenic diet.
But then comes the fun part!
The researchers flip-flopped the groups, now giving ATX-304 to the mice represented by the white triangles.
What happened?
A complete weight-inversion effect!
The animals that started taking ATX-304 rapidly lost weight, while the animals taken off of it gained weight.
Then, around day 56, the groups were switched again.
Like the ultimate weight yo-yo effect!
But that’s not even the best part…
Energy intake was higher in the groups losing weight at any given time point.
In other words, ATX-304 induced weight loss despite no reduction—and in some cases, even an increase—in food intake.
What Happens to Energy Flow on ATX-304?
But if energy was being burned off:
Where was it coming from?
And where is it going?
Well, let’s consider some of the biological effects of AMPK:
It increases the liberation of fat from fat cells (adipocytes)
It supports beta-oxidation (the burning of fat in mitochondria)
And it increases the uptake of glucose from the blood into muscle
This last aspect (glucose → muscle) deserves particular attention because of the mechanism involved.
Normally, insulin triggers a signaling cascade in muscle cells.
This causes GLUT4 glucose transporters to move from intracellular storage to the surface of the muscle cell.
That, in turn, allows muscle to pull glucose out of the blood, improving blood sugar control and ultimately burning that glucose for energy.
All good.
However, in type 2 diabetes and insulin resistance more broadly, this signal becomes blunted.
Muscle cells no longer respond to insulin as effectively, leading to impaired glucose uptake and elevated blood sugar.
But there’s a metabolic back door.
There’s a way to partially circumvent this pathway that becomes activated during exercise and depends on, you guessed it, AMPK (red box).
AMPK activation—whether through exercise or ATX-304—allows muscle to pull glucose from the bloodstream without waiting for insulin’s permission.
It also improves insulin sensitivity, ultimately delivering a powerful metabolic one-two punch.
But that first effect (insulin-independent glucose update) is remarkable because it’s normally reserved for one physiological state: Exercise.
Except now, we can recreate it with ATX-304!
The animal data are remarkable.
The human data are encouraging.
But what people are reporting outside the clinical trials... that’s what really caught my attention…
In the rest of this letter for StayCurious Metabolism premium members, we will dive into how ATX-304:
Improves glucose control
Enhances exercise performance
Reduces body fat while preserving muscle
Then we will turn to:
The human clinical trial data
How people are actually using it today
Real-world reports
Administration
Dosing & Access
If you want to join a community of curious people passionate about metabolic health, come see why StayCurious Metabolism is the fasting growing premium science newsletter on the platform, and why so many members call it the “best investment I’ve made in my healthy journey.”
